| GlaxoSmithKline AG - Benlysta 400 mg, Pulver zur Herstellung einer Infusionslösung |
| 61532 | | 02 | | Benlysta 400 mg | | Pulver zur Herstellung einer Infusionslösung | | L04AG04 | | | | 14.06.2012 | | |
|
| Composition |
| Praeparatio cryodesiccata: belimumabum 400 mg, acidum citricum monohydricum, natrii citras dihydricus, saccharum, polysorbatum 80 pro vitro. |
| Packungsbestandteile |
| Praeparatio cryodesiccata: | | | Lyophilisate | | | | | | | | Active Agent | Dose |
|---|
| Belimumabum | 400 mg |
| | BAG: Active Agent | Dose |
|---|
| Belimumabum | 400 mg |
| | | | Inactive agents |
|---|
| Citric Acid Monohydrate | | Natrii Citras Dihydricus | | Polysorbatum 80 | | Saccharum |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 002 | Durchstechflasche(n) | 521.67 | 583.75 | A | SL | No |
|
